Kailash Prasad Selected Research

secoisolariciresinol diglucoside

1/2016	Prevention and treatment of atherosclerosis with flaxseed-derived compound secoisolariciresinol diglucoside.
1/2015	Secoisolariciresinol diglucoside abrogates oxidative stress-induced damage in cardiac iron overload condition.
12/2013	Secoisolariciresinol Diglucoside (SDG) Isolated from Flaxseed, an Alternative to ACE Inhibitors in the Treatment of Hypertension.
12/2010	Natural products in regression and slowing of progression of atherosclerosis.
3/2008	Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
1/2008	Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
2/2007	Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kailash Prasad Research Topics

Disease

30	Atherosclerosis 03/2021 - 03/2003
11	Hypercholesterolemia 06/2016 - 03/2003
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 09/2003
7	Hypertension (High Blood Pressure) 09/2021 - 12/2003
7	Atherosclerotic Plaque (Atheroma) 01/2011 - 03/2003
6	Coronary Artery Disease (Coronary Atherosclerosis) 03/2022 - 04/2005
3	Obesity 03/2022 - 09/2015
3	Dyslipidemias (Dyslipidemia) 09/2021 - 09/2015
3	Hyperhomocysteinemia 09/2021 - 03/2002
3	Ischemia 09/2020 - 01/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2008
3	Stroke (Strokes) 01/2016 - 04/2005
3	Body Weight (Weight, Body) 09/2009 - 04/2005
2	Thoracic Aortic Aneurysm 12/2019 - 02/2016
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2015 - 12/2014
2	Coronary Disease (Coronary Heart Disease) 06/2015 - 12/2010
2	ST Elevation Myocardial Infarction 03/2011 - 08/2010
2	Hyperlipidemias (Hyperlipidemia) 01/2011 - 02/2010
2	Non-ST Elevated Myocardial Infarction 08/2010 - 01/2009
2	Reperfusion Injury 01/2008 - 02/2007
1	Glaucoma 02/2022
1	Persistent Infection 09/2021
1	Chronic Renal Insufficiency 09/2021
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2019
1	Abdominal Aortic Aneurysm 12/2019
1	Alzheimer Disease (Alzheimer's Disease) 09/2019
1	Hypertrophy 06/2019
1	Ischemic Stroke 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2016
1	Hyperthyroidism 03/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Iron Overload 01/2015
1	Inflammation (Inflammations) 01/2015
1	Heart Failure 12/2014
1	Cardiomyopathies (Cardiomyopathy) 12/2014
1	Cardiac Arrhythmias (Arrythmia) 12/2014
1	Shock 01/2014
1	Aortic Diseases 08/2013
1	Peripheral Arterial Disease 03/2012

Drug/Important Bio-Agent (IBA)

13	Advanced Glycation End ProductsIBA 03/2022 - 01/2009
12	AntioxidantsIBA 03/2022 - 03/2003
12	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019 - 09/2003
12	CholesterolIBA 01/2016 - 09/2003
11	LipidsIBA 01/2011 - 09/2003
8	Vitamin E FDA LinkGeneric 06/2014 - 01/2009
7	secoisolariciresinol diglucosideIBA 01/2016 - 02/2007
7	LignansIBA 01/2016 - 04/2005
6	C-Reactive ProteinIBA 09/2021 - 09/2004
5	Malondialdehyde (Propanedial)IBA 06/2016 - 03/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 09/2004
5	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2008
4	CytokinesIBA 12/2019 - 09/2004
4	Biomarkers (Surrogate Marker)IBA 12/2016 - 01/2009
4	Receptor for Advanced Glycation End ProductsIBA 06/2016 - 01/2009
4	oxidized low density lipoproteinIBA 03/2008 - 04/2005
3	LigandsIBA 06/2019 - 01/2009
3	LDL CholesterolIBA 01/2016 - 09/2003
3	Linseed Oil (Flaxseed Oil)IBA 01/2016 - 09/2003
3	Glucose (Dextrose)FDA LinkGeneric 12/2014 - 01/2008
3	HomocysteineIBA 09/2006 - 01/2003
2	human esRAGE proteinIBA 03/2021 - 03/2017
2	Matrix Metalloproteinases (MMPs)IBA 12/2019 - 02/2016
2	NF-kappa B (NF-kB)IBA 12/2019 - 01/2009
2	HDL CholesterolIBA 06/2016 - 09/2003
2	EnzymesIBA 01/2014 - 02/2010
2	ResveratrolIBA 03/2012 - 12/2010
2	thymoquinoneIBA 01/2011 - 01/2008
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2010 - 01/2009
2	AlbuminsIBA 02/2010 - 01/2008
2	CreatinineIBA 02/2010 - 01/2008
2	Platelet Activating FactorIBA 06/2007 - 09/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 02/2022
1	Cholinergic Agents (Cholinergics)IBA 09/2019
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	Cell Adhesion MoleculesIBA 01/2017
1	Dietary CholesterolIBA 01/2016
1	SmokeIBA 06/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	IronIBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	AMP-Activated Protein KinasesIBA 01/2015
1	InterferonsIBA 01/2015
1	SugarsIBA 12/2014
1	High Fructose Corn SyrupIBA 12/2014
1	Dietary Sucrose (Table Sugar)IBA 12/2014
1	Sweetening Agents (Sweeteners)IBA 12/2014
1	Sirolimus (Rapamycin)FDA Link 06/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2014
1	prostaglandin-inositol cyclic phosphateIBA 01/2014
1	1,3-dimethylthioureaIBA 01/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2013
1	Vitamin B Complex (B Vitamins)IBA 09/2012
1	Apolipoproteins E (ApoE)IBA 03/2012
1	LDL Receptors (LDL Receptor)IBA 03/2012
1	ApolipoproteinsIBA 03/2012

Therapy/Procedure

1	Trabeculectomy (Trabeculoplasty) 02/2022
1	Tertiary Prevention 09/2021
1	Complementary Therapies (Alternative Medicine) 01/2016